Cushing's syndrome in an 81-year-old patient treated with budesonide and amiodarone

Eur J Gastroenterol Hepatol. 2000 Sep;12(9):1041-2. doi: 10.1097/00042737-200012090-00015.

Abstract

This is the first report of Cushing's syndrome under oral budesonide treatment. An 81-year-old man known for paroxysmal atrial fibrillation and chronic renal insufficiency, treated with 6 mg budesonide for collagenous colitis, developed Cushing's syndrome under co-administration of amiodarone. The Cushing's syndrome disappeared after discontinuation of the amiodarone treatment. Metabolism of the two medications by hepatic cytochrome P 450 3A may explain the development of Cushing's syndrome.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Aged, 80 and over
  • Amiodarone / therapeutic use
  • Anti-Arrhythmia Agents / therapeutic use
  • Anti-Inflammatory Agents / adverse effects*
  • Anti-Inflammatory Agents / therapeutic use
  • Atrial Fibrillation / drug therapy
  • Budesonide / adverse effects*
  • Budesonide / therapeutic use
  • Cushing Syndrome / chemically induced*
  • Cytochrome P-450 Enzyme System / metabolism
  • Humans
  • Male

Substances

  • Anti-Arrhythmia Agents
  • Anti-Inflammatory Agents
  • Budesonide
  • Cytochrome P-450 Enzyme System
  • Amiodarone